Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis
Authors
Keywords
Aspirin, Clopidogrel, <em class=EmphasisTypeItalic >CYP2C19</em>, <em class=EmphasisTypeItalic >CES1</em>, Ischemic, Stenosis
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 72, Issue 10, Pages 1195-1204
Publisher
Springer Nature
Online
2016-07-24
DOI
10.1007/s00228-016-2094-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial
- (2016) Grant W. Reed et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation
- (2016) Noriaki Tabata et al. Journal of Cardiology
- Clopidogrel Resistance Increases Rate of Recurrent Stroke and Other Vascular Events in Chinese Population
- (2016) Xingyang Yi et al. Journal of Stroke & Cerebrovascular Diseases
- Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures
- (2016) Ichiro Nakagawa et al. Journal of Stroke & Cerebrovascular Diseases
- Clopidogrel Resistance Increases Rate of Recurrent Stroke and Other Vascular Events in Chinese Population
- (2016) Xingyang Yi et al. Journal of Stroke & Cerebrovascular Diseases
- Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures
- (2016) Ichiro Nakagawa et al. Journal of Stroke & Cerebrovascular Diseases
- Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting
- (2016) Xiao-Qing Li et al. PLoS One
- Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans
- (2015) EK Tarkiainen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients
- (2015) Nicolas Simon et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Recurrent Stroke while on Antiplatelet Therapy
- (2015) Seby John et al. NEUROLOGIC CLINICS
- C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention
- (2015) Beatriz Calderón-Cruz et al. THROMBOSIS RESEARCH
- CYP2C19 Metabolizer Status and Clopidogrel Efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) Study
- (2015) C. W. McDonough et al. Journal of the American Heart Association
- CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel: A Meta-Analysis
- (2014) M. J. Sorich et al. Circulation-Cardiovascular Genetics
- Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis
- (2014) Xiaowen Hou et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease
- (2014) Thomas Bergmeijer et al. THROMBOSIS AND HAEMOSTASIS
- Aspirin resistance: Where are we now?
- (2013) Okay Abaci et al. Anadolu Kardiyoloji Dergisi-The Anatolian Journal of Cardiology
- Genetic Variation in PEAR1 Is Associated With Platelet Aggregation and Cardiovascular Outcomes
- (2013) Joshua P. Lewis et al. Circulation-Cardiovascular Genetics
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial
- (2013) Colin P Derdeyn et al. LANCET
- Mechanisms of aspirin resistance
- (2013) Christopher N. Floyd et al. PHARMACOLOGY & THERAPEUTICS
- Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes
- (2013) Stacey Knight et al. THROMBOSIS AND HAEMOSTASIS
- Epidemiological Factors of Stroke: A Survey of the Current Status in China
- (2013) Haixin Sun et al. Journal of Stroke
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Drug Resistance and Pseudoresistance
- (2012) Tilo Grosser et al. CIRCULATION
- Besides CYP2C19, PON1 genetic variant influences post-clopidogrel platelet reactivity in Chinese patients
- (2012) Hongyi Wu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association between polymorphisms of eNOS and GPx-1 genes, activity of free-radical processes and in-stent restenosis
- (2012) Yu. A. Shuvalova et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis
- (2012) Jia Su et al. PLoS One
- Cytochromes P450 Catalyze Both Steps of the Major Pathway of Clopidogrel Bioactivation, whereas Paraoxonase Catalyzes the Formation of a Minor Thiol Metabolite Isomer
- (2011) Patrick M. Dansette et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
- (2011) J T Delaney et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Anti-Platelet Therapy and Aspirin Resistance – Clinically and Chemically Relevant?
- (2011) M. Rafferty et al. CURRENT MEDICINAL CHEMISTRY
- Aspirin resistance: Effect of clinical, biochemical and genetic factors
- (2011) Richard FitzGerald et al. PHARMACOLOGY & THERAPEUTICS
- Enhanced Clopidogrel Responsiveness in Smokers
- (2010) Kyung Woo Park et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
- (2010) Thomas G. Brott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis
- (2008) Hao-Jie Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pharmacogenetics of aspirin resistance: a comprehensive systematic review
- (2008) Timothy Goodman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
- (2008) Hitinder S. Gurm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiological Transition of Stroke in China
- (2008) Dong Zhao et al. STROKE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now